| ACE2 | angiotensin-converting enzyme 2 |
| ANF | atrial natriuretic factor |
| A wave | mitral valve inflow (late) |
| B-mode | brightness mode |
| BNP | B-type natriuretic peptide |
| DCM | dilated cardiomyopathy |
| DRX | disordered relaxed state |
| ECG | Electrocardiogram |
| E wave | mitral valve inflow (early) |
| Ea | arterial elastance |
| Ees | end-systolic elastance |
| EF | ejection fraction |
| ESPVR | end-systolic pressure-volume relationship |
| FS | fractional shortening |
| HCQ | hydroxychloroquine |
| LV | left ventricle |
| LVPM | LV papillary muscles |
| LVPW | LV posterior wall |
| M-mode | time-motion display of the ultrasound wave |
| Mant-ATP | fluorescent (N-methylanthraniloyl) analog of ATP |
| NTg | non-transgenic |
| P1 | amplitude of fast DRX phase |
| P2 | amplitude of slow SRX phase |
| P-V loops | Pressure-Volume hemodynamic measurements |
| RV | right ventricle |
| SRX | super-relaxed state |
| T1 | nucleotide turnover lifetime in DRX |
| T2 | nucleotide turnover lifetime in SRX |
| TEM | transmission electron microscopy |
| Tg | transgenic |